Related Experiment Video
Updated: Aug 20, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Lymphotoxin and LIGHT signaling pathways and target genes
Kirsten Schneider1, Karen G Potter, Carl F Ware
1Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA.
Abstract:
Lymphotoxins (LT alpha and LT beta), LIGHT [homologous to LT, inducible expression, competes with herpes simplex virus (HSV) glycoprotein D for HSV entry mediator (HVEM), a receptor expressed on T lymphocytes], tumor necrosis factor (TNF), and their specific receptors LT beta R, HVEM, and TNF receptor 1 (TNFR1) and TNFR2, form the immediate family of the larger TNF superfamily. These cytokines establish a critical communication system required for the development of secondary lymphoid tissues; however, knowledge of the target genes activated by these signaling pathways is limited. Target genes regulated by the LT alpha beta-LT beta R pathway include the tissue-organizing chemokines, CXCL13, CCL19, and CCL21, which establish cytokine circuits that regulate LT expression on lymphocytes, leading to organized lymphoid tissue. Infectious disease models have revealed that LT alpha beta pathways are also important for innate and adaptive immune responses involved in host defense. Here, regulation of interferon-beta by LT beta R and TNFR signaling may play a crucial role in certain viral infections. Regulation of autoimmune regulator in the thymus via LT beta R implicates LT/LIGHT involvement in central tolerance. Dysregulated expression of LIGHT overrides peripheral tolerance leading to T-cell-driven autoimmune disease. Blockade of TNF/LT/LIGHT pathways as an intervention in controlling autoimmune diseases is attractive, but such therapy may have risks. Thus, identifying and understanding the target genes may offer an opportunity to fine-tune inhibitory interventions.
Insights
Tumor necrosis factor superfamily members, including lymphotoxins (LT) and LIGHT, are crucial for immune system development and function. Understanding their target genes is key to developing targeted therapies for autoimmune diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Lymphotoxins (LT alpha and LT beta), LIGHT, and tumor necrosis factor (TNF) are key members of the TNF superfamily.
- These molecules and their receptors (LT beta R, HVEM, TNFR1, TNFR2) are vital for secondary lymphoid tissue development.
- The specific target genes activated by these signaling pathways remain largely unknown.
Purpose of the Study:
- To elucidate the target genes regulated by the lymphotoxin alpha beta-LT beta R pathway.
- To understand the role of LT/LIGHT signaling in immune responses, viral infections, and autoimmune diseases.
- To explore the potential of targeting TNF superfamily pathways for autoimmune disease intervention.
Main Methods:
- Analysis of target genes regulated by the LT alpha beta-LT beta R pathway.
- Investigation of LT beta R and TNFR signaling in viral infections.
- Examination of LT beta R's role in central tolerance and LIGHT's role in peripheral tolerance.
- Assessment of TNF/LT/LIGHT pathway blockade for autoimmune disease treatment.
Main Results:
- The LT alpha beta-LT beta R pathway regulates tissue-organizing chemokines (CXCL13, CCL19, CCL21), establishing cytokine circuits for lymphoid tissue organization.
- LT alpha beta pathways are essential for innate and adaptive immune responses in host defense.
- LT beta R and TNFR signaling may regulate interferon-beta, impacting viral infections.
- LT beta R signaling in the thymus is implicated in central tolerance, while dysregulated LIGHT expression can lead to autoimmune disease.
Conclusions:
- Identifying and understanding target genes of TNF superfamily signaling pathways is critical for immune regulation.
- These pathways play significant roles in lymphoid tissue development, immune responses, and maintaining tolerance.
- Targeting TNF/LT/LIGHT pathways offers potential therapeutic strategies for autoimmune diseases, but risks associated with blockade must be considered.
Related Concept Videos
Cell Signaling in Plants
Photoreceptors and Plant Responses to Light
Photoreceptors and Visual Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway
Signal Transduction: Overview
Typically, signal transduction involves three...

